Protara Therapeutics Announces Second Quarter 2020 Financial Results and Business Overview
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a development-stage company developing treatments for rare […]
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a development-stage company developing treatments for rare […]
LATHAM, N.Y., Aug. 03, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of zero emission hydrogen […]
GEORGE TOWN, Grand Cayman, Aug. 03, 2020 (GLOBE NEWSWIRE) — O2Micro® International Limited (NASDAQ Global Select Market: OIIM), a global leader in the […]
– Age-range for all EPIDIOLEX indications expanded to include patients one year of age and older –– Third indication approved for […]
PETAH TIKVA, Israel, Aug. 03, 2020 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused […]
HINGHAM, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) has further strengthened the Company’s capabilities and […]
RALEIGH, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — BMC Stock Holdings, Inc. (Nasdaq: BMCH) (“BMC” or the “Company”), a leading […]
NEW YORK and VIENNA, Austria, Aug. 03, 2020 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing […]
ROCKVILLE, Md. and CHESTERBROOK, Pa., Aug. 03, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a leading biopharmaceutical company in […]
DUBLIN, Ireland, Aug. 03, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]